Clinical Trial Update: A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 double-blind trial evaluating Zorevunersen for Dravet syndrome is currently recruiting to assess efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• Zorevunersen

Snippet

Sponsor: Stoke Therapeutics, Inc | Conditions: Dravet Syndrome | Phase 3 | Status: RECRUITING